American beef producers will soon be able to sell again to the Chinese market, ending a 13-year ban that has proved to be costly.
Investors are lighting up for tobacco stocks despite anti-smoking campaigns and proposed cigarette tax hikes in several states.
Mikhail Shamolin, CEO of Sistema, discusses Sistema's diversification to build up its portfolio.
Andrey Guryev, CEO of PhosAgro, shares his views on the recent Russian election and says promises of privatization of state assets will be honored.
CNBC's Geoff Cutmore reports on Russian fertilizer company PhosAgro and the impact of the Bayer Monsanto merger on agriculture companies.
Food makers and restaurants are increasingly overhauling classic foods to get a health and wellness halo and to boost sales.
Alliance for Bio-Integrity's Steven Druker says the big concern from the merger is the lack of rigorous testing needed for genetically-modified foods.
Farming as we know it could be transformed soon by autonomous tractors and robots that could perform tasks now done by humans.
Bayer has won over Monsanto with a takeover offer of around $66 billion, ending months of wrangling after increasing its bid for a third time.
Monsanto, Macy's and Ford are making headlines on Wall Street this Wednesday morning.
Dr Brian McGee, engagement manager at Novasecta, discusses Bayer's expected acquisition of agrochemical firm Monsanto.
The U.S. accused China of having unfair agricultural subsidies for three key crops, adding to the growing tension between the two nations.
Craft beer enthusiasts may be disappointed with the selection of pumpkin beers this fall. A pumpkin crop shortage has meant that many brewers couldn’t get their hands on the coveted orange fruit.
2016 has been a banner year for boutique banks, but they all got shut out of Monday morning's mega-merger.
Agrium and Potash will combine to become the largest crip nutrient company in the world.
The stakes are high for U.S. agribusinesses if the TPP is not ratified by Congress, says the U.S. Department of Agriculture's Alexis Taylor.
The "Fast Money Halftime Report" traders weigh in on Deutsche Bank's bullish bet on Caterpillar.
German drugmaker Bayer and Monsanto are closing in on a deal, with Monsanto telling Bayer that it is "close" on price, sources told CNBC Tuesday.
John Rountree, managing partner at Novasecta, discusses the viability of Bayer's latest attempt to buy Monsanto.
New Zealand's Prime Minister John Key has taken an unusual approach to defending the country's high immigration rate.